ATE89829T1 - Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung. - Google Patents
Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.Info
- Publication number
- ATE89829T1 ATE89829T1 AT85900447T AT85900447T ATE89829T1 AT E89829 T1 ATE89829 T1 AT E89829T1 AT 85900447 T AT85900447 T AT 85900447T AT 85900447 T AT85900447 T AT 85900447T AT E89829 T1 ATE89829 T1 AT E89829T1
- Authority
- AT
- Austria
- Prior art keywords
- pro
- glu
- leu
- val
- asp
- Prior art date
Links
- 102100034296 Natriuretic peptides A Human genes 0.000 title abstract 2
- 108010031762 cardiodilatin Proteins 0.000 title abstract 2
- QGFSVPWZEPKNDV-BRTFOEFASA-N ranp Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)[C@@H](C)CC)C1=CC=CC=C1 QGFSVPWZEPKNDV-BRTFOEFASA-N 0.000 title abstract 2
- 239000000813 peptide hormone Substances 0.000 abstract 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 abstract 1
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 abstract 1
- 125000000899 L-alpha-glutamyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C(O[H])=O 0.000 abstract 1
- 101150118523 LYS4 gene Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 210000004900 c-terminal fragment Anatomy 0.000 abstract 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 abstract 1
- 230000004992 fission Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/841—Muscles; heart
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833346953 DE3346953A1 (de) | 1983-12-24 | 1983-12-24 | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung |
| PCT/DE1984/000279 WO1985002850A1 (en) | 1983-12-24 | 1984-12-21 | Cardiodilatine, a new peptide hormone and production process thereof |
| EP85900447A EP0167575B2 (de) | 1983-12-24 | 1984-12-21 | Cardiodilatin, neues peptidhormon und verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE89829T1 true ATE89829T1 (de) | 1993-06-15 |
Family
ID=6218045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85900447T ATE89829T1 (de) | 1983-12-24 | 1984-12-21 | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung. |
Country Status (6)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60136596A (ja) * | 1983-12-26 | 1985-07-20 | Suntory Ltd | ペプチド及びこれを有効成分とする利尿剤 |
| JPH0672155B2 (ja) * | 1984-08-24 | 1994-09-14 | 塩野義製薬株式会社 | α−ｈＡＮＰ抗血清作製用ポリペプチド |
| JP3042782B2 (ja) * | 1985-11-05 | 2000-05-22 | サイオス インコーポレイテッド | 心房性ナトリウム尿排泄亢進ペプチド類似化合物 |
| DE3619633A1 (de) * | 1986-06-11 | 1987-12-17 | Hoechst Ag | Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
| US5449751A (en) * | 1987-03-02 | 1995-09-12 | Pharma Bissendorf Peptide Gmbh | Cardiodilatin fragment, process for preparing same and use thereof |
| JPH0773508B2 (ja) * | 1989-11-17 | 1995-08-09 | 寳酒造株式会社 | Ｌ―アスパラギンのアミド結合の水解方法及び試薬 |
| DE4032271A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Ingelheim Kg | Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE4032269A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Ingelheim Kg | Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE4032268A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Ingelheim Kg | Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US5281700A (en) * | 1992-08-11 | 1994-01-25 | The Regents Of The University Of California | Method of recovering endothelial membrane from tissue and applications thereof |
| EP0763061B1 (de) * | 1994-06-02 | 2002-10-30 | Forssmann, Wolf-Georg, Prof. Dr. med. | Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung |
| US5512592A (en) * | 1994-09-09 | 1996-04-30 | Wake Forest University | Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine |
| AT407674B (de) * | 1998-09-29 | 2001-05-25 | Biomedica Gmbh | Verfahren zur bestimmung von atrialem natriuretischem peptid (anp) |
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
| US6135469A (en) * | 1999-05-10 | 2000-10-24 | Link Mfg., Ltd. | Tag axle mounting system |
| DK1865976T3 (da) * | 2005-04-07 | 2012-07-23 | Cardiopep Pharma Gmbh | Anvendelse af natriuretiske peptider til behandling af hjertesvigt |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| WO2009086166A1 (en) * | 2007-12-19 | 2009-07-09 | Ekr Therapeutics, Inc. | Room temperature stable, lyophilized natriuretic peptide formulations |
| WO2012115772A2 (en) | 2011-02-25 | 2012-08-30 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
| US20130244937A1 (en) | 2011-09-02 | 2013-09-19 | Nile Therapeutics, Inc. | Chimeric natriuretic peptide compositions and methods of preparation |
| CN105025918A (zh) | 2013-01-25 | 2015-11-04 | 卡迪欧伦蒂斯有限公司 | 利尿钠肽、利尿肽或血管舒张肽用于治疗心血管适应症的方法 |
| EP3244878B1 (en) | 2015-01-12 | 2022-08-10 | Enteris BioPharma, Inc. | Solid oral dosage forms |
| WO2016131943A1 (en) | 2015-02-20 | 2016-08-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of obesity and complications arising therefrom including type 2 diabetes |
| WO2022029499A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Methods of treating refractory ascites |
| WO2022029497A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Ularitide for use in methods of treating refractory ascites |
| EP4333846A1 (en) | 2021-05-06 | 2024-03-13 | Rigshospitalet | Diagnosing and treating critically ill subjects |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4531780Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1967-01-24 | 1970-12-05 | ||
| JPS4531787Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1967-12-28 | 1970-12-05 | ||
| ES8407097A1 (es) * | 1982-05-12 | 1984-08-16 | Harvard College | Un procedimiento para obtener una proteina hibrida. |
| JPS6028999A (ja) * | 1983-06-30 | 1985-02-14 | Maruho Kk | 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法 |
| US4731245A (en) * | 1983-12-29 | 1988-03-15 | Kitasato Kenkyusho | Vaccine, antigen and antibody for treating microorganisms of the MCLS-type streptococcus sanguis |
| JPS60199819A (ja) * | 1984-03-23 | 1985-10-09 | Kowa Co | トロンビン結合性物質およびその製法 |
| US4851349A (en) * | 1984-04-12 | 1989-07-25 | Mitsubishi Chemical Industries Limited | Expression vectors encoding cardionatrin and cardiodilatin |
| US4798787A (en) * | 1984-09-19 | 1989-01-17 | Cetus Corporation | Peptide antibodies and their use in detecting oncogene products |
| GB8432401D0 (en) * | 1984-12-21 | 1985-02-06 | Bennett C E | Liver fluke antigens |
| US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
-
1983
- 1983-12-24 DE DE19833346953 patent/DE3346953A1/de active Granted
-
1984
- 1984-12-21 WO PCT/DE1984/000279 patent/WO1985002850A1/de active IP Right Grant
- 1984-12-21 DE DE8585900447T patent/DE3486154D1/de not_active Expired - Lifetime
- 1984-12-21 AT AT85900447T patent/ATE89829T1/de not_active IP Right Cessation
- 1984-12-21 JP JP60500395A patent/JPH0822876B2/ja not_active Expired - Lifetime
- 1984-12-21 US US06/769,627 patent/US4751284A/en not_active Expired - Lifetime
- 1984-12-21 EP EP85900447A patent/EP0167575B2/de not_active Expired - Lifetime
-
1988
- 1988-01-04 US US07/140,736 patent/US4782044A/en not_active Expired - Lifetime
- 1988-08-08 US US07/229,706 patent/US4895932A/en not_active Expired - Lifetime
-
1994
- 1994-01-13 JP JP6002150A patent/JPH0772146A/ja active Pending
-
1995
- 1995-10-06 JP JP7260453A patent/JPH08224094A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US4895932A (en) | 1990-01-23 |
| JPS61500848A (ja) | 1986-05-01 |
| DE3346953C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-03 |
| DE3486154D1 (de) | 1993-07-01 |
| JPH0772146A (ja) | 1995-03-17 |
| EP0167575B1 (de) | 1993-05-26 |
| EP0167575B2 (de) | 1999-10-27 |
| US4751284A (en) | 1988-06-14 |
| EP0167575A1 (de) | 1986-01-15 |
| JPH0822876B2 (ja) | 1996-03-06 |
| DE3346953A1 (de) | 1985-08-14 |
| WO1985002850A1 (en) | 1985-07-04 |
| JPH08224094A (ja) | 1996-09-03 |
| US4782044A (en) | 1988-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE89829T1 (de) | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung. | |
| US4079127A (en) | Thymosin alpha 1 | |
| Ling et al. | Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. | |
| Atassi et al. | Immunochemistry of sperm whale myoglobin. I. Specific interaction of some tryptic peptides and of peptides containing all the reactive regions of the antigen | |
| Mutt et al. | Structure of the Porcine Vasoactive Intestinal Octacosapeptide: The Amino‐Acid Sequence. Use of Kallikrein in Its Determination | |
| Sanger | The chemistry of insulin | |
| ES2044841T3 (es) | Procedimiento de preparacion de peptidos sinteticos con actividad de interleuquin 1 humana. | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| DE3583824D1 (de) | Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins. | |
| KR870002163A (ko) | 펩티드의 제조방법 | |
| Katsoyannis | Synthesis of Insulin: Availability of A and B chains readily leads to the synthesis of this protein. | |
| DE68914205T2 (de) | Zyklische GRF-Analoge. | |
| DE69128779D1 (de) | Epitheline: neue cystein-reiche, den wachstum modulierende proteine | |
| HUT63652A (en) | Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy | |
| Sabsay et al. | Domain structure and sequence distribution in dentin phosphophoryn | |
| Li | Preliminary investigations on the action of pepsin on human pituitary growth hormone | |
| Roy et al. | Human α-crystallin. II. Characterization of the protein isolated from the periphery of cataractous lenses | |
| Sandberg et al. | Primary structure of porcine tropoelastin | |
| EULITZ et al. | Amyloid fibrils derived from V-region together with C-region fragments from a λII-immunoglobulin light chain (HAR) | |
| MAGHUIN‐ROGISTER et al. | Porcine Thyrotropin: The Amino‐Acid Sequence of the α and β Subunits | |
| Murray et al. | Biologically active hormonal fragment isolated from bovine parathyroid glands (BPTH 1-65) | |
| GB1294771A (en) | Thyrocalcitonin derivative | |
| US4732972A (en) | Polypeptides having growth hormone releasing activity | |
| DE69932804D1 (de) | Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung | |
| EP0070569B1 (en) | Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |